700,0
+0,00%
2026-10-16
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +164.4% | +35.9% | 2 / 3 | -61.1% | +1.51 pp | +1.06 pp | -0.5% | 0.00 | — | 21,3 | −61,1% | 0,1 | +161,0% | — | 8.74 | — |
| Pts | 12 | 8 | 8 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 700,0 (close price on 2026-10-16)EPS (TTM): −56,3
Financial charts
1.Revenue & growth
VND bn21,3Q2/26
1.Revenue & growth
VND bn21,3Q2/26
2.Profit & growth
VND bn0,14Q2/26
3.Profit mix (Penman)
VND bn-1,52Q2/26
4.Margins & cost structure
%1.6%Q2/26
5.Returns & cash cycle
% · days-0.2%Q2/26
6.Earnings quality & cash
VND bn-59,7Q2/26
7.Asset structure
VND bn343Q2/26
8.Funding & debt health
VND bn · times343Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %-13,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %5Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-140%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26